Published in Oncotarget on February 07, 2017
Diagnostic Capacity of RASSF1A Promoter Methylation as a Biomarker in Tissue, Brushing, and Blood Samples of Nasopharyngeal Carcinoma. EBioMedicine (2017) 0.75
Short stature homeobox 2 methylation as a potential noninvasive biomarker in bronchial aspirates for lung cancer diagnosis. Oncotarget (2017) 0.75
Clinical significance of p16(INK4A) and p14(ARF) promoter methylation in renal cell carcinoma: a meta-analysis. Oncotarget (2017) 0.75
p16 Methylation was associated with the development, age, hepatic viruses infection of hepatocellular carcinoma, and p16 expression had a poor survival: A systematic meta-analysis (PRISMA). Medicine (Baltimore) (2017) 0.75
Global cancer statistics, 2012. CA Cancer J Clin (2015) 53.52
Quantitative synthesis in systematic reviews. Ann Intern Med (1997) 11.72
Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst (2005) 9.38
Letter: Nomogram for Bayes theorem. N Engl J Med (1975) 6.64
14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage. Nature (1999) 5.44
Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA (2016) 4.06
Screening for breast cancer with mammography. Cochrane Database Syst Rev (2013) 4.04
High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. Proc Natl Acad Sci U S A (2000) 2.70
Summary receiver operating characteristic curve analysis techniques in the evaluation of diagnostic tests. Ann Thorac Surg (2005) 2.14
Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer. Oncogene (2001) 1.89
Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma. Oncogene (2000) 1.76
Prognostic significance of methylated RASSF1A and PITX2 genes in blood- and bone marrow plasma of breast cancer patients. Breast Cancer Res Treat (2011) 1.71
Comment on: Heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol (2009) 1.49
A meta-analytic method for summarizing diagnostic test performances: receiver-operating-characteristic-summary point estimates. Med Decis Making (1993) 1.46
Promoter-region hypermethylation and gene silencing in human cancer. Curr Top Microbiol Immunol (2000) 1.38
Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer. Int J Mol Sci (2015) 1.09
The prognostic role of RASSF1A promoter methylation in breast cancer: a meta-analysis of published data. PLoS One (2012) 1.08
Prostate cancer is characterized by epigenetic silencing of 14-3-3sigma expression. Oncogene (2004) 1.08
Role of TET enzymes in DNA methylation, development, and cancer. Genes Dev (2016) 1.08
Quantitative hypermethylation of a small panel of genes augments the diagnostic accuracy in fine-needle aspirate washings of breast lesions. Breast Cancer Res Treat (2007) 0.99
Meta-analyses of gene methylation and smoking behavior in non-small cell lung cancer patients. Sci Rep (2015) 0.98
The tumour associated antigen CA15.3 in primary breast cancer. Evaluation of 667 cases. Br J Cancer (1991) 0.96
Downregulation of 14-3-3sigma in ovary, prostate and endometrial carcinomas is associated with CpG island methylation. Mod Pathol (2005) 0.96
Global histone post-translational modifications and cancer: Biomarkers for diagnosis, prognosis and treatment? World J Biol Chem (2015) 0.94
Epigenetic modifications in prostate cancer. Epigenomics (2014) 0.93
14-3-3sigma gene silencing during melanoma progression and its role in cell cycle control and cellular senescence. Mol Cancer (2009) 0.92
Promoter methylation of BRCA1 in the prognosis of breast cancer: a meta-analysis. Breast Cancer Res Treat (2013) 0.91
Inactivation of 14-3-3 sigma by promoter methylation correlates with metastasis in nasopharyngeal carcinoma. J Cell Biochem (2009) 0.90
Aberrant methylation profile of 14-3-3 sigma and its reduced transcription/expression levels in Chinese sporadic female breast carcinogenesis. Med Oncol (2009) 0.90
[Biomarkers in breast cancer]. Gan To Kagaku Ryoho (2004) 0.88
DNA methylation of circulating DNA: a marker for monitoring efficacy of neoadjuvant chemotherapy in breast cancer patients. Tumour Biol (2012) 0.88
Study of promoter methylation pattern of 14-3-3 sigma gene in normal and cancerous tissue of breast: A potential biomarker for detection of breast cancer in patients. Adv Biomed Res (2012) 0.87
CpG island hypermethylation as a biomarker for the early detection of lung cancer. Methods Mol Biol (2015) 0.87
Detection of aberrant methylation of a six-gene panel in serum DNA for diagnosis of breast cancer. Oncotarget (2016) 0.86
Clinical significance of Stratifin, ERalpha and PR promoter methylation in tumor and serum DNA in Indian breast cancer patients. Clin Biochem (2009) 0.84
Multigene methylation in serum of sporadic Chinese female breast cancer patients as a prognostic biomarker. Oncology (2008) 0.84
Breast Cancer Tumor Suppressors: A Special Emphasis on Novel Protein Nischarin. Cancer Res (2015) 0.82
Hypermethylation of tumor suppressor genes BRCA1, p16 and 14-3-3sigma in serum of sporadic breast cancer patients. Onkologie (2007) 0.81
Blood-Based Screening for Colon Cancer: A Disruptive Innovation or Simply a Disruption? JAMA (2016) 0.81
Ultrasound screening of contralateral breast after surgery for breast cancer. Eur J Radiol (2014) 0.81
Methylation of SFRP2 gene as a promising noninvasive biomarker using feces in colorectal cancer diagnosis: a systematic meta-analysis. Sci Rep (2016) 0.79
Integrated analysis of genome-wide DNA methylation and gene expression profiles identifies potential novel biomarkers of rectal cancer. Oncotarget (2016) 0.77
Protocadherin 17 functions as a tumor suppressor suppressing Wnt/β-catenin signaling and cell metastasis and is frequently methylated in breast cancer. Oncotarget (2016) 0.77
Epigenetic changes of TIMP-3, GSTP-1 and 14-3-3 sigma genes as indication of status of chronic inflammation and cancer. Int J Biol Markers (2014) 0.77
Optimizing Digital Mammographic Image Quality for Full-Field Digital Detectors: Artifacts Encountered during the QC Process. Radiographics (2015) 0.76
Pattern of Breast Cancer Distribution in Ghana: A Survey to Enhance Early Detection, Diagnosis, and Treatment. Int J Breast Cancer (2016) 0.76
CA153 in Breast Secretions as a Potential Molecular Marker for Diagnosing Breast Cancer: A Meta Analysis. PLoS One (2016) 0.76
Diagnostic Capacity of RASSF1A Promoter Methylation as a Biomarker in Tissue, Brushing, and Blood Samples of Nasopharyngeal Carcinoma. EBioMedicine (2017) 0.75
Short stature homeobox 2 methylation as a potential noninvasive biomarker in bronchial aspirates for lung cancer diagnosis. Oncotarget (2017) 0.75
Short stature homeobox 2 methylation as a potential noninvasive biomarker in bronchial aspirates for lung cancer diagnosis. Oncotarget (2017) 0.75